Cartesian Therapeutics, Inc. (RNAC) Stock Price History
Historical prices from 2016 to 2026
Loading 10-year price history...
RNAC Historical Performance
Short-Term Returns
RNAC Stock Price Trajectory (2016–2026)
As of May 8, 2026, Cartesian Therapeutics, Inc. (RNAC) trades at $8.16, representing a -19.6% return over the past year. The stock has delivered a -91.3% total return over five years (-38.6% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $840.00 on November 28, 2016. From this peak, RNAC has corrected -99.0%, currently trading 2% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers KYMR (+190.7% 1Y), IMVT (+96.1% 1Y), and ARQT (+50.8% 1Y), RNAC has underperformed the peer group average. Compare RNAC vs KYMR →
RNAC Historical Price Data (2025–2026)
Showing 30 of 2,484 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 8.07 | 8.22 | 7.92 | 8.16 | 176K | -2.16% |
| 2026-05-06 | 7.46 | 8.40 | 7.38 | 8.34 | 278K | +12.86% |
| 2026-05-05 | 7.01 | 7.46 | 6.83 | 7.39 | 296K | +6.64% |
| 2026-05-04 | 6.21 | 7.00 | 6.21 | 6.93 | 230K | +11.41% |
| 2026-05-01 | 6.20 | 6.42 | 5.95 | 6.22 | 205K | 0.00% |
| 2026-04-30 | 6.41 | 6.55 | 6.21 | 6.22 | 117K | -3.86% |
| 2026-04-29 | 6.74 | 6.74 | 6.40 | 6.47 | 157K | -4.85% |
| 2026-04-28 | 7.05 | 7.21 | 6.77 | 6.80 | 94K | -4.09% |
| 2026-04-27 | 7.07 | 7.33 | 6.90 | 7.09 | 232K | +5.04% |
| 2026-04-24 | 7.05 | 7.12 | 6.71 | 6.75 | 118K | -3.16% |
| 2026-04-23 | 6.84 | 7.00 | 6.65 | 6.97 | 93K | +1.16% |
| 2026-04-22 | 7.15 | 7.38 | 6.75 | 6.89 | 105K | -0.29% |
| 2026-04-21 | 6.98 | 7.16 | 6.82 | 6.91 | 125K | -0.43% |
| 2026-04-20 | 7.03 | 7.15 | 6.75 | 6.94 | 147K | -1.42% |
| 2026-04-17 | 6.54 | 7.24 | 6.54 | 7.04 | 372K | +10.34% |
| 2026-04-16 | 6.01 | 6.40 | 6.00 | 6.38 | 286K | +6.51% |
| 2026-04-15 | 6.33 | 6.47 | 5.97 | 5.99 | 193K | -5.67% |
| 2026-04-14 | 5.97 | 6.37 | 5.94 | 6.35 | 280K | +7.08% |
| 2026-04-13 | 6.02 | 6.45 | 5.88 | 5.93 | 241K | -0.84% |
| 2026-04-10 | 6.19 | 6.30 | 5.82 | 5.98 | 173K | -3.24% |
| 2026-04-09 | 6.16 | 6.32 | 6.03 | 6.18 | 174K | +0.49% |
| 2026-04-08 | 6.55 | 6.57 | 6.03 | 6.15 | 153K | -2.07% |
| 2026-04-07 | 6.09 | 6.36 | 5.96 | 6.28 | 129K | +0.64% |
| 2026-04-06 | 6.28 | 6.59 | 6.18 | 6.24 | 93K | -0.32% |
| 2026-04-02 | 6.27 | 6.36 | 6.16 | 6.26 | 60K | -2.03% |
| 2026-04-01 | 6.21 | 6.50 | 6.15 | 6.39 | 104K | +3.90% |
| 2026-03-31 | 6.00 | 6.44 | 5.97 | 6.15 | 155K | +4.59% |
| 2026-03-30 | 5.86 | 5.90 | 5.67 | 5.88 | 153K | +0.51% |
| 2026-03-27 | 6.08 | 6.17 | 5.60 | 5.85 | 319K | -3.78% |
| 2026-03-26 | 6.17 | 6.57 | 6.07 | 6.08 | 127K | -2.72% |
See RNAC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RNAC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RNAC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRNAC — Frequently Asked Questions
Quick answers to the most common questions about buying RNAC stock.
How has RNAC stock performed recently?
RNAC declined -19.6% over the past year, below its 5-year annualized CAGR of -38.6%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is RNAC's all-time high price?
Cartesian Therapeutics, Inc. reached $840.00 on 2016-11-28. The 52-week high is $15.57. Current 1-year return of -19.6% places the stock further from historical peaks.
Where can I download RNAC historical price data?
This page provides RNAC daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.